Fate Therapeutics
FATE
FATE
136 hedge funds and large institutions have $1.28B invested in Fate Therapeutics in 2019 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 38 increasing their positions, 42 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
2% less call options, than puts
Call options by funds: $6.45M | Put options by funds: $6.59M
10% less repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 42
Holders
136
Holding in Top 10
5
Calls
$6.45M
Puts
$6.59M
Top Buyers
| 1 | +$19.4M | |
| 2 | +$14.3M | |
| 3 | +$13.4M | |
| 4 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$10.3M |
| 5 |
NAMA
Nikko Asset Management Americas
New York
|
+$10.3M |
Top Sellers
| 1 | -$15.3M | |
| 2 | -$6.09M | |
| 3 | -$6.09M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$5.33M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$4.5M |